References
Campana D, Farrant J, Inamdar N, Webster AD, Janossy G (1990) Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 145(6):1675–1680
Conley ME (1992) Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol 10:215–238, Review
Sigmon JR, Kasasbeh E, Krishnaswamy G (2008) X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature. Clin Mol Allergy 6:5
Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, Conley ME, Cunningham-Rundles C, Ochs HD (2006) X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine (Baltimore) 85(4):193–202
Kanegane H, Taneichi H, Nomura K, Futatani T, Miyawaki T (2005) Severe neutropenia in Japanese patients with X-linked agammaglobulinemia. J Clin Immunol 25(5):491–495
Jacobs ZD, Guajardo JR, Anderson KM (2008) XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematolo Oncol 30(8):631–634
Farrar JE, Rohrer J, Conley ME (1996) Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 81(3):271–276
Noordzij JG, de Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, de Groot R, van Dongen JJ (2002) Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children. Pediatr Res 51(2):159–168
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tendas, A., Niscola, P., Dentamaro, T. et al. Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). Ann Hematol 89, 949–951 (2010). https://doi.org/10.1007/s00277-009-0891-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-009-0891-7